| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.8M | -21.9% |
| Cost of Revenue | $186K | -11.8% |
| R&D Expense | $33.8M | +54.1% |
| SG&A Expense | $20.3M | +44.3% |
| Operating Income | -$51.5M | -1572.1% |
| Interest Expense | $1.4M | +7.7% |
| Net Income | -$49.1M | -1695.9% |
| EPS (Basic) | -$1.48 | -770.6% |
| EPS (Diluted) | -$1.48 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $30.6M | — |
| Short-term Investments | $57.0M | -10.9% |
| Accounts Receivable | $99K | +3.1% |
| Inventory | $146K | -47.1% |
| Current Assets | $89.1M | — |
| Total Assets | $95.2M | +39.9% |
| Current Liabilities | $11.2M | +542.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$46.1M | -2820.7% |
| Capital Expenditures | $78K | -86.8% |
| Investing Cash Flow | $10.7M | -88.5% |
| Financing Cash Flow | $46.2M | +149.9% |
| Free Cash Flow | -$46.2M | -2029.0% |
| -770.6% |
| Total Liabilities |
| $27.2M |
| +270.0% |
| Stockholders' Equity | $68.0M | +1079.8% |